New Pharmaceuticals research report from GlobalData is now available from Fast Market Research

Boston, MA -- (SBWire) -- 08/08/2012 --GlobalData, the industry analysis specialist, has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - Australia". The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Australia. It identifies key trends, and most importantly, provides valuable insights into the trends and segmentation of the pharmaceutical and medical devices market. It is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.

In 2010, Australia's population was 22.4 million, largely due to a positive balance between the birth rate and mortality rate and net overseas immigration. The mortality rate is almost steady due to Australia's strong healthcare infrastructure and medical and diagnostic services. The pharmaceutical market was estimated at $14.9 billion in 2010 and is expected to reach $30.5 billion by 2020 at a projected CAGR of 7.4%. The medical device market size was worth approximately $6.5 billion in 2011 and is expected to reach $10 billion by 2020 at a projected CAGR of 4.8%.

View Full Report Details and Table of Contents

The positive trends in the healthcare market can be attributed primarily to -

- Easy market access to pharmaceutical drugs
- Increasing awareness of the need for the early detection of lifestyle and chronic diseases
- Government-subsidized prescription medicines through the Pharmaceutical Benefit Scheme (PBS) for all eligible, general or concessional patients
- Annual review and addition of expensive innovative drugs to the PBS drug list

Scope

The report provides information on the Australian healthcare, regulatory and reimbursement landscape, and includes -

- Overview of the pharmaceutical and medical devices market, including size, segmentation, and key drivers and barriers.
- Profiles and SWOT analyses of the major players in the pharmaceutical and medical devices market. The key players covered for the pharmaceutical market are Pfizer, AstraZeneca, Novartis, Sanofi and GlaxoSmithKline, and the key players covered for the medical devices market are Siemens Healthcare, GE Healthcare, DePuy Inc, F. Hoffmann-la Roche and Stryker Corporation.
- Insightful review of the reimbursement and regulatory landscape, with details of the healthcare reimbursement process, regulatory agencies and market authorization processes for new drug and medical devices.
- Detailed analysis of Australia's political and economic environment, including the economic indicators, demographics, healthcare infrastructure and healthcare expenditure.
- An overview of the opportunities for and challenges to growth in the healthcare market.

About Fast Market Research
Fast Market Research is an online aggregator and distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff will help you find the right research to fit your requirements and your budget. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156.

Browse all Pharmaceuticals research reports at Fast Market Research

You may also be interested in these related reports:

- Healthcare, Regulatory and Reimbursement Landscape - Spain
- Healthcare, Regulatory and Reimbursement Landscape - Germany
- Healthcare, Regulatory and Reimbursement Landscape - Japan
- Healthcare, Regulatory and Reimbursement Landscape Russia
- Healthcare, Regulatory and Reimbursement Landscape Vietnam
- Healthcare, Regulatory and Reimbursement Landscape - Italy
- Healthcare, Regulatory and Reimbursement Landscape - UK
- Healthcare, Regulatory and Reimbursement Landscape - US
- Healthcare, Regulatory and Reimbursement Landscape - France
- Healthcare, Regulatory and Reimbursement Landscape - Singapore